Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages from our genes.
Study reveals novel approach to promote efficient uptake of ASOs into cancer cells
- Post author:
- Post published:April 16, 2024
- Post category:uncategorized